NeoGenomics, Inc. Increase (Decrease) in Deferred Income Taxes
NeoGenomics, Inc. (NEO) reported Increase (Decrease) in Deferred Income Taxes of $1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-07-28
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2026-06-30 was $626.00K, a 36.96% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2026-03-31 was $769.00K, a 42.14% increase year-over-year.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2025-12-31 was $2.69M, a 73.14% increase year-over-year.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2025-09-30 was -$869.00K, a 456.15% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for fiscal 2025 was $3.36M, a 9.41% increase from fiscal 2024.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for fiscal 2024 was $3.07M, a 72.57% decline from fiscal 2023.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for fiscal 2023 was $11.19M, a 30.47% decline from fiscal 2022.
- NeoGenomics, Inc. increase (decrease) in deferred income taxes for fiscal 2022 was $16.10M, a 155.56% increase from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|
| 2026-06-30 | $626.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.40M 10-Q · filed 2026-07-28 | $4.09M derived: sum of 3 quarters · filed 2026-07-28 | $3.22M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $769.00K 10-Q · filed 2026-04-28 | $3.46M derived: sum of 2 quarters · filed 2026-04-28 | $2.59M derived: sum of 3 quarters · filed 2026-04-28 | $3.59M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.82M derived: sum of 2 quarters · filed 2026-02-17 | $2.82M derived: sum of 3 quarters · filed 2026-07-28 | $3.36M 10-K · filed 2026-02-17 |
| 2025-09-30 | -$869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $124.00K derived: sum of 2 quarters · filed 2026-07-28 | $665.00K 10-Q · filed 2025-10-28 | $2.22M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $993.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.53M 10-Q · filed 2026-07-28 | $3.09M derived: sum of 3 quarters · filed 2026-07-28 | $3.33M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $541.00K 10-Q · filed 2026-04-28 | $2.10M derived: sum of 2 quarters · filed 2026-04-28 | $2.34M derived: sum of 3 quarters · filed 2026-04-28 | $2.82M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.80M derived: sum of 2 quarters · filed 2026-02-17 | $2.27M derived: sum of 3 quarters · filed 2026-02-17 | $3.07M 10-K · filed 2026-02-17 |
| 2024-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $719.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.51M 10-Q · filed 2025-10-28 | $3.33M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $475.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.27M 10-Q · filed 2025-07-29 | $3.08M derived: sum of 3 quarters · filed 2026-02-17 | $6.52M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $795.00K 10-Q · filed 2025-04-29 | $2.61M derived: sum of 2 quarters · filed 2026-02-17 | $6.05M derived: sum of 3 quarters · filed 2026-02-17 | $8.95M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $5.25M derived: sum of 2 quarters · filed 2026-02-17 | $8.16M derived: sum of 3 quarters · filed 2026-02-17 | $11.19M 10-K · filed 2026-02-17 |
| 2023-09-30 | $3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $6.34M derived: sum of 2 quarters · filed 2024-11-05 | $9.38M 10-Q · filed 2024-11-05 | $12.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $5.94M 10-Q · filed 2024-07-30 | $9.26M derived: sum of 3 quarters · filed 2025-02-18 | $12.54M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $3.04M 10-Q · filed 2024-04-30 | $6.35M derived: sum of 2 quarters · filed 2025-02-18 | $9.64M derived: sum of 3 quarters · filed 2025-02-18 | $15.37M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $6.60M derived: sum of 2 quarters · filed 2025-02-18 | $12.33M derived: sum of 3 quarters · filed 2025-02-18 | $16.10M 10-K · filed 2025-02-18 |
| 2022-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $9.02M derived: sum of 2 quarters · filed 2023-11-06 | $12.78M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $9.49M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $3.77M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $6.30M 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |